Charles Y. Lin
Impact in
- Molecular Biology top 0.5%
- Genomics and Chromatin Dynamics
- Protein Degradation and Inhibitors
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Cancer Research top 1%
Papers in
-
- Protein Degradation and Inhibitors 22
- Genomics and Chromatin Dynamics 9
- RNA Research and Splicing 7
- Epigenetics and DNA Methylation 7
- Ubiquitin and proteasome pathways 7
- Hematology 16
- Multiple Myeloma Research and Treatments 9
- Co-authors
- Peter B. Rahl (9 shared papers)Richard A. Young (18 shared papers)Brian J. Abraham (3 shared papers)Denes Hnisz (2 shared papers)David A. Orlando (2 shared papers)Michael H. Kagey (1 shared paper)Richard A. Young (1 shared paper)Warren A. Whyte (1 shared paper)
- Journals
- Blood (11 papers)Cell (6 papers)Cancer Research (6 papers)Cell Reports (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Charles Y. Lin
62 papers receiving 8.6k citations
Charles Y. Lin's Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 7.3k
- Cancer Research 1.1k
- Hematology 795
- Oncology 1.2k
- Immunology 857
Countries citing papers authored by Charles Y. Lin
This map shows the geographic impact of Charles Y. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Y. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Y. Lin more than expected).
Fields of papers citing papers by Charles Y. Lin
This network shows the impact of papers produced by Charles Y. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Y. Lin. The network helps show where Charles Y. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Y. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes Hit paper breakdown → | 2013 | 2677 |
| 2 | Transcriptional Amplification in Tumor Cells with Elevated c-Myc Hit paper breakdown → | 2012 | 1119 |
| 3 | c-Myc Regulates Transcriptional Pause Release Hit paper breakdown → | 2010 | 977 |
| 4 | Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2013 | 550 |
| 5 | NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis Hit paper breakdown → | 2014 | 453 |
| 6 | 2011 | 352 | |
| 7 | 2013 | 291 | |
| 8 | 2013 | 260 | |
| 9 | 2018 | 195 | |
| 10 | 2016 | 169 | |
| 11 | 2016 | 152 | |
| 12 | Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers | 2015 | 139 |
| 13 | 2018 | 129 | |
| 14 | 2019 | 123 | |
| 15 | 2013 | 122 | |
| 16 | 2019 | 115 | |
| 17 | 2014 | 106 | |
| 18 | 2017 | 98 | |
| 19 | 2021 | 87 | |
| 20 | 2017 | 61 |
About Charles Y. Lin
Charles Y. Lin is a scholar working on Molecular Biology, Hematology, Oncology, Surgery and Pathology and Forensic Medicine, having authored 64 papers that have together received 8.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (22 papers), Multiple Myeloma Research and Treatments (9 papers), Genomics and Chromatin Dynamics (9 papers), RNA Research and Splicing (7 papers), Cancer-related Molecular Pathways (7 papers), Anesthesia and Pain Management (7 papers), Epigenetics and DNA Methylation (7 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Molecular Biology (7.3k citations), Cancer Research (1.1k citations), Hematology (795 citations), Oncology (1.2k citations) and Immunology (857 citations). Charles Y. Lin has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Peter B. Rahl, Richard A. Young, Brian J. Abraham, Denes Hnisz, David A. Orlando, Michael H. Kagey, Richard A. Young, Warren A. Whyte, James E. Bradner and Tong Ihn Lee. Their work appears in journals such as Blood, Cell, Cancer Research, Cell Reports and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.